Jenne Kyle (CIK 1791857) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-17). Recent activity: Buy IONS (12,226 shares), Sell IONS (4,902 shares), Buy IONS (32,602 shares), Sell IONS (21,191 shares), Sell IONS (16,086 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-17 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf GL Pdt Str Ofcr | Buy | 12,226 | $0 |
| 2026-04-17 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf GL Pdt Str Ofcr | Sell | 4,902 | $368,488 |
| 2026-03-11 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf GL Pdt Str Ofcr | Buy | 32,602 | $1.5M |
| 2026-03-11 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf GL Pdt Str Ofcr | Sell | 21,191 | $1.6M |
| 2026-03-11 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf GL Pdt Str Ofcr | Sell | 16,086 | $1.2M |
| 2026-03-11 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf GL Pdt Str Ofcr | Buy | 4,675 | $162,176 |
| 2026-01-20 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf GL Pdt Str Ofcr | Buy | 7,013 | $0 |
| 2026-01-20 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf GL Pdt Str Ofcr | Sell | 1,823 | $138,475 |
| 2025-04-17 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf GL Pdt Str Ofcr | Buy | 12,226 | $0 |
| 2025-04-17 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Chf GL Pdt Str Ofcr | Sell | 3,016 | $85,534 |
Source: SEC Form 4 filings · as of 2026-04-17